Product 6
DK-PRO A GRANULES
PRO A GRANULES, a natural supplement for kidney support, metabolizes nitrogenous waste that has diffused from the bloodstream into the bowel. When these waste products accumulate in high concentrations in the blood, they become highly toxic and can cause severe damage to many organ systems if they are not properly excreted. Nitrogenous wastes are utilized as nutrients. As probiotics grow and multiply, they consume more nitrogenous waste and therefore effectively help maintain healthy kidney function.
Due to the overloaded and impaired kidneys, a buildup of poisonous wastes occurs in the bloodstream. Certain probiotic microorganisms can utilize urea, uric acid and creatinine and other toxins as nutrients for growth. These probiotics multiply and metabolize larger quantities of uremic toxins, facilitating the increased diffusion of these toxins from the circulating blood into the bowel across the lining of the intestinal walls. Ultimately, these microbes are excreted in the feces (normally microbes make up 50% of feces by weight). In this manner, the enteric toxin reduction technology uses probiotic organisms to transform the colon into a blood cleansing agent, which, with the aid of microbes, indirectly removes toxic wastes and helps eliminate them as fecal matter. Consequently, it is possible to maintain a healthy kidney function with the oral use of PRO A GRANULES, a natural supplement for kidney failure. PRO A GRANULES have been clinically tested and shown to be safe, effective, and free of serious side effects when taken for as long as months.
The Chronic Kidney Disease (CKD) is a growing health problem worldwide. CKD patients have high levels of inflammation, and their blood uremic toxins passively diffuse into the bowel. The present invention introduces PRO A GRANULES composition to be used for enteric dialysis to eliminate toxins and other metabolic waste products, this composition consists of oral Ispaghula seed/husk in granules form coated with three types of polyclonal antibodies that adsorb uremic toxins and their precursors within the gastrointestinal tract, allowing them to be excreted in the feces preventing any progression of CKD. Our solution: Our novel product offers a real solution for patients suffering from early and advanced renal diseases instead of exhausting dialysis and expensive transplantation. A Nutraceutical Approach to Pre-Dialysis our work in the area of nutraceuticals is the development of a product to augment normal kidney functions such as the eradication of nitrogenous wastes. Vitro trails 1.1 Determination the efficient of antibody in neutralizing process. 1.2 Study the effect of colon protease enzymes in reducing the neutralizing antibodies effectivity.
Summary Our studies using PRO A GRANULES for Enteric Dialysis showed marked reduction in levels of various uremic toxins like urea, creatinine, and uric acid with an improvement in the quality of life.
10% of the population worldwide is affected by chronic kidney disease (CKD), and millions die each year because they do not have access to affordable treatment. Chronic kidney disease can be treated. With early diagnosis and treatment, it is possible to slow or stop the progression of kidney disease. “Treatments are urgently needed to reduce the risk of progression to kidney failure and improve the lives of patients with kidney disease.
Our solution: Our novel product offers a real solution for patients suffering from early and advanced renal diseases instead of exhausting dialysis and expensive transplantation.
Our work in the area of nutraceuticals is the development of a product to augment normal kidney functions such as the eradication of nitrogenous wastes.
Our preclinical studies using PRO A granules for Enteric Dialysis showed marked reduction in levels of various uremic toxins like urea, creatinine, and uric acid with an improvement in the quality of life.
Users
• Patients with secondary, third and fourth stage kidney diseases.
• patients with late-stage kidney diseases
• Diabetic patients with nephropathy
• patients with 2-3 timed dialysis/week